Privium Fund Management B.V.
In its 13F for Q4 2025 (holdings as of December 31, 2025, filed February 3, 2026), Privium Fund Management B.V. reported 57 stock positions worth $543.1 million. Its top holding was Tesla (TSLA) at 18.9% of the portfolio, followed by Shopify Class A (SHOP, 12.2%) and Spotify Technology (SPOT, 7.3%). Compared with Q3 2025, it opened 6 new positions, sold out of 8, added to 25 and reduced 15. The biggest buy was Lemonade (LMND, shares +71%) and the biggest sale Spotify Technology (SPOT, shares −28%).
- Most Recent 13F
- Q2 2026
- Location
- AMSTERDAM, P7
- CIK
- 0001795097
- Portfolio Value
- $543.1M (Q4 2025)
- SEC Filing
- 0001754960-26-000150 ↗ filed Feb 3, 2026
Holdings Value
Holdings 57 stocks · $543.1M
| TSLA Tesla Inc. | 18.92% | 228,500 | $102.8M | Reduce -6.3% |
| SHOP Shopify Inc. Class A | 12.15% | 410,000 | $66.0M | Reduce -1.2% |
| SPOT Spotify Technology SA | 7.27% | 68,000 | $39.5M | Reduce -28.4% |
| PLTR Palantir Technologies Inc. Class A | 6.55% | 200,000 | $35.5M | No change |
| AMZN Amazon.com Inc. | 5.14% | 121,000 | $27.9M | Reduce -18.8% |
| ARWR Arrowhead Pharmaceuticals Inc. | 4.87% | 398,204 | $26.4M | Reduce -16.0% |
| IONS Ionis Pharmaceuticals Inc. | 3.51% | 240,824 | $19.1M | Reduce -3.2% |
| COIN Coinbase Global Inc. Class A | 3.29% | 79,000 | $17.9M | No change |
| LMND Lemonade Inc. | 3.25% | 248,259 | $17.7M | Add +71.2% |
| SE Sea Ltd.-ADR | 3.24% | 138,000 | $17.6M | Reduce -13.8% |
| NVDA Nvidia Corp. | 2.78% | 81,000 | $15.1M | No change |
| BIIB Biogen Inc. | 2.38% | 73,480 | $12.9M | Add +41.5% |
| AMD Advanced Micro Devices | 2.37% | 60,000 | $12.8M | No change |
| PRQR Proqr Therapeutics NV | 1.99% | 5,357,762 | $10.8M | Add +7.2% |
| IREN Iren Ltd. filed as IREN LIMITED | 1.95% | 280,000 | $10.6M | Add +115.4% |
| ASTS Ast Spacemobile Inc. | 1.94% | 145,000 | $10.5M | Add +31.8% |
| AXSM Axsome Therapeutics Inc. | 1.91% | 56,878 | $10.4M | Add +7.9% |
| QURE Uniqure NV | 1.83% | 416,270 | $10.0M | Add +7.8% |
| ARQT Arcutis Biotherapeutics Inc. | 1.64% | 305,972 | $8.9M | No change |
| RARE Ultragenyx Pharmaceutical Inc. | 1.51% | 357,502 | $8.2M | Add +23.4% |
| VRDN Viridian Therapeutics Inc. | 0.99% | 173,516 | $5.4M | New |
| URGN Urogen Pharma Ltd. | 0.93% | 214,622 | $5.0M | Add +9.2% |
| VRTX Vertex Pharmaceuticals Inc. | 0.78% | 9,355 | $4.2M | Add +12.7% |
| MRK Merck & Co. Inc. | 0.71% | 36,593 | $3.9M | Reduce -43.2% |
| WVE Wave Life Sciences Ltd. | 0.60% | 193,010 | $3.3M | Add +13.5% |
| ENGN Engene Holdings Inc. | 0.59% | 352,087 | $3.2M | New |
| BNTX Biontech SE-ADR | 0.58% | 33,300 | $3.2M | Add +75.3% |
| KRYS Krystal Biotech Inc. | 0.55% | 12,170 | $3.0M | No change |
| ABEV Ambev SA-ADR | 0.48% | 1,063,174 | $2.6M | Add +18.5% |
| ZLAB Zai Lab Ltd.-ADR | 0.43% | 132,189 | $2.3M | No change |
| CRSP Crispr Therapeutics AG | 0.41% | 42,874 | $2.2M | Add +7.2% |
| BEAM Beam Therapeutics Inc. | 0.36% | 71,500 | $2.0M | Add +17.2% |
| LXEO Lexeo Therapeutics Inc. | 0.35% | 192,550 | $1.9M | Add +0.1% |
| STOK Stoke Therapeutics Inc. | 0.32% | 55,000 | $1.7M | New |
| MGTX Meiragtx Holdings PLC | 0.29% | 200,000 | $1.6M | Add +22.7% |
| FDMT 4D Molecular Therapeutics Inc. | 0.29% | 210,000 | $1.6M | Add +6.3% |
| SLB SLB Ltd. filed as SLB LIMITED | 0.27% | 38,805 | $1.5M | Add +97.0% |
| MRNA Moderna Inc. | 0.27% | 49,594 | $1.5M | Add +5.5% |
| HIMS Hims & Hers Health Inc. | 0.24% | 40,000 | $1.3M | No change |
| RNAC Cartesian Therapeutics Inc. | 0.23% | 172,500 | $1.2M | New |
| VZLA Vizsla Silver Corp. | 0.21% | 204,654 | $1.1M | No change |
| PFE Pfizer Inc. | 0.17% | 37,750 | $940K | No change |
| SRPT Sarepta Therapeutics Inc. | 0.17% | 43,000 | $925K | New |
| TSHA Taysha Gene Therapies Inc. | 0.17% | 164,900 | $907K | Add +22.2% |
| NOV Nov Inc. | 0.15% | 53,126 | $830K | Reduce -16.8% |
| SA Seabridge Gold Inc. | 0.13% | 23,756 | $703K | Reduce -51.0% |
| AUTL Autolus Therapeutics PLC | 0.12% | 326,245 | $649K | Add +5.6% |
| RCKT Rocket Pharmaceuticals Inc. | 0.11% | 170,146 | $597K | Reduce -60.7% |
| RIG Transocean Ltd. | 0.11% | 139,604 | $577K | Add +36.9% |
| SD Sandridge Energy Inc. | 0.10% | 38,792 | $560K | Reduce -23.0% |
| VYGR Voyager Therapeutics Inc. | 0.07% | 95,000 | $373K | Add +111.1% |
| FATE Fate Therapeutics Inc. | 0.07% | 369,100 | $363K | Add +10.8% |
| VAL Valaris Ltd. | 0.06% | 6,315 | $318K | Reduce -24.1% |
| NE Noble Corp. PLC | 0.06% | 10,849 | $306K | Reduce -24.1% |
| URNM Sprott Uranium Miners ETF | 0.05% | 5,407 | $297K | Reduce -52.8% |
| TDW Tidewater Inc. | 0.05% | 5,483 | $277K | No change |
| NOMD Nomad Foods Ltd. | 0.02% | 8,199 | $103K | New |
Portfolio Sells Q3 2025 → Q4 2025
| SPOT Spotify Technology SA | Reduce -28.4% | 7.27% | −4.65 |
| SE Sea Ltd.-ADR | Reduce -13.8% | 3.24% | −1.90 |
| AMZN Amazon.com Inc. | Reduce -18.8% | 5.14% | −0.74 |
| TSLA Tesla Inc. | Reduce -6.3% | 18.92% | −0.59 |
| ABVX Abivax SA-ADR | Sold out | 0.00% | −0.46 |
| RNAM Avidity Biosciences Inc. | Sold out | 0.00% | −0.42 |
| ROIV Roivant Sciences Ltd. | Sold out | 0.00% | −0.35 |
| ACAD Acadia Pharmaceuticals Inc. | Sold out | 0.00% | −0.27 |
| MRK Merck & Co. Inc. | Reduce -43.2% | 0.71% | −0.26 |
| ALXO Alx Oncology Holdings Inc. | Sold out | 0.00% | −0.17 |
| RCKT Rocket Pharmaceuticals Inc. | Reduce -60.7% | 0.11% | −0.14 |
| PAAS Pan American Silver Corp. | Sold out | 0.00% | −0.13 |
| RXRX Recursion Pharmaceuticals-A | Sold out | 0.00% | −0.10 |
| SA Seabridge Gold Inc. | Reduce -51.0% | 0.13% | −0.08 |
| URNM Sprott Uranium Miners ETF | Reduce -52.8% | 0.05% | −0.07 |
| SBSW Sibanye-Stillwater Ltd.-ADR | Sold out | 0.00% | −0.05 |
| NE Noble Corp. PLC | Reduce -24.1% | 0.06% | −0.02 |
| VAL Valaris Ltd. | Reduce -24.1% | 0.06% | −0.01 |
| NOV Nov Inc. | Reduce -16.8% | 0.15% | +0.00 |
| SD Sandridge Energy Inc. | Reduce -23.0% | 0.10% | +0.00 |
| IONS Ionis Pharmaceuticals Inc. | Reduce -3.2% | 3.51% | +0.58 |
| SHOP Shopify Inc. Class A | Reduce -1.2% | 12.15% | +1.06 |
| ARWR Arrowhead Pharmaceuticals Inc. | Reduce -16.0% | 4.87% | +1.93 |
Portfolio Buys Q3 2025 → Q4 2025
| LMND Lemonade Inc. | Add +71.2% | 3.25% | +1.86 |
| BIIB Biogen Inc. | Add +41.5% | 2.38% | +1.07 |
| VRDN Viridian Therapeutics Inc. | New | 0.99% | +0.99 |
| ASTS Ast Spacemobile Inc. | Add +31.8% | 1.94% | +0.97 |
| IREN Iren Ltd. | Add +115.4% | 1.95% | +0.85 |
| AXSM Axsome Therapeutics Inc. | Add +7.9% | 1.91% | +0.76 |
| ENGN Engene Holdings Inc. | New | 0.59% | +0.59 |
| WVE Wave Life Sciences Ltd. | Add +13.5% | 0.60% | +0.38 |
| STOK Stoke Therapeutics Inc. | New | 0.32% | +0.32 |
| BNTX Biontech SE-ADR | Add +75.3% | 0.58% | +0.25 |
| RNAC Cartesian Therapeutics Inc. | New | 0.23% | +0.23 |
| URGN Urogen Pharma Ltd. | Add +9.2% | 0.93% | +0.22 |
| VRTX Vertex Pharmaceuticals Inc. | Add +12.7% | 0.78% | +0.20 |
| SRPT Sarepta Therapeutics Inc. | New | 0.17% | +0.17 |
| SLB SLB Ltd. | Add +97.0% | 0.27% | +0.15 |
| ABEV Ambev SA-ADR | Add +18.5% | 0.48% | +0.12 |
| LXEO Lexeo Therapeutics Inc. | Add +0.1% | 0.35% | +0.12 |
| BEAM Beam Therapeutics Inc. | Add +17.2% | 0.36% | +0.10 |
| TSHA Taysha Gene Therapies Inc. | Add +22.2% | 0.17% | +0.09 |
| PRQR Proqr Therapeutics NV | Add +7.2% | 1.99% | +0.08 |
| MGTX Meiragtx Holdings PLC | Add +22.7% | 0.29% | +0.05 |
| MRNA Moderna Inc. | Add +5.5% | 0.27% | +0.05 |
| RIG Transocean Ltd. | Add +36.9% | 0.11% | +0.05 |
| VYGR Voyager Therapeutics Inc. | Add +111.1% | 0.07% | +0.03 |
| AUTL Autolus Therapeutics PLC | Add +5.6% | 0.12% | +0.03 |
| NOMD Nomad Foods Ltd. | New | 0.02% | +0.02 |
| FATE Fate Therapeutics Inc. | Add +10.8% | 0.07% | −0.01 |
| FDMT 4D Molecular Therapeutics Inc. | Add +6.3% | 0.29% | −0.02 |
| CRSP Crispr Therapeutics AG | Add +7.2% | 0.41% | −0.05 |
| RARE Ultragenyx Pharmaceutical Inc. | Add +23.4% | 1.51% | −0.05 |
| QURE Uniqure NV | Add +7.8% | 1.83% | −2.22 |
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 61 | $544.2M | TSLA, SHOP, AMD, AMZN, IONS |
| Q1 2026 | 60 | $480.3M | TSLA, SHOP, SPOT, PLTR, AMZN |
| Q4 2025 | 57 | $543.1M | TSLA, SHOP, SPOT, PLTR, AMZN |
| Q3 2025 | 59 | $556.3M | TSLA, SPOT, SHOP, PLTR, AMZN |
| Q2 2025 | 55 | $463.5M | SPOT, TSLA, SHOP, PLTR, AMZN |
| Q1 2025 | 56 | $383.6M | SPOT, TSLA, SHOP, PLTR, SE |
| Q4 2024 | 59 | $437.0M | TSLA, SPOT, SHOP, AMZN, PLTR |
| Q3 2024 | 82 | $402.0M | TSLA, SPOT, SHOP, AMZN, ASTS |
| Q2 2024 | 85 | $358.2M | TSLA, SPOT, AMZN, SHOP, SNOW |
| Q1 2024 | 75 | $342.7M | SPOT, SHOP, TSLA, AMZN, SNOW |